BXF-25591-13866
3 vaccinations
11 coded responses
33 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 924 / CA
- Registered
- 2021-06-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-01
Registered in v-safe
-
2021-06-01
Dose 1 — Pfizer-BioNTech
- 2021-06-01
-
2021-06-02
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Fair · Muscle or body achesFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
-
2021-06-04
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: FairFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-05
- 2021-06-06
- 2021-06-07
-
2021-06-08
Survey response — day 7, dose 1MedDRA: Depression — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Increase in depressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-15
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Dose 2 — Pfizer-BioNTech
- 2021-06-22
-
2021-06-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Muscle or body achesAdult check-in
-
2021-06-24
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Depression — Feeling: Fair · Site: Redness, Swelling · Fatigue or tirednessFree text: Increase in depression and anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-26
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Condition aggravated, Depression, Pre-existing disease — Feeling: Poor · Site: SwellingFree text: Severe depression and anxiety; increase in problems with memory (hemorrhagic stroke in 05/2019)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-27
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Depression, Memory impairment, Pre-existing disease — Feeling: Poor · Site: Swelling · Fatigue or tirednessFree text: Severe depression and anxiety; increase in memory problems (previous hemorrhagic stroke 05/19)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-28
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Condition aggravated, Depression, Pre-existing disease — Feeling: Poor · Fatigue or tirednessFree text: Severe depression/anxiety; increase in memory problems (05/2019 hemorrhagic stroke)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-29
Survey response — day 7, dose 2MedDRA: Anxiety, Depression — Feeling: Fair · Site: SwellingFree text: Increase in depression/anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-06
- 2021-07-13
- 2021-07-21
-
2021-07-28
Survey response — day 35, dose 2MedDRA: Anxiety, Depression — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe depression and anxiety.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-03
Survey response — day 42, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-23
- 2021-12-22
-
2022-02-01
Dose 3 — Pfizer-BioNTech
- 2022-02-09
- 2022-02-15
- 2022-02-23
- 2022-03-01
- 2022-03-08
- 2022-03-15
- 2022-05-05
- 2022-08-02
- 2023-02-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-01 | Pfizer-BioNTech | |
| 2 | 2021-06-22 | Pfizer-BioNTech | No |
| 3 | 2022-02-01 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Systemic reaction (other): Dizziness
Release 8 — day 7, dose 1
Systemic reaction (other): Increase in depression
Release 9 — day 14, dose 1
Symptoms: Fatigue
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Increase in depression and anxiety
Systemic reaction (other): Severe depression and anxiety; increase in problems with memory (hemorrhagic stroke in 05/2019)
Systemic reaction (other): Severe depression and anxiety; increase in memory problems (previous hemorrhagic stroke 05/19)
Systemic reaction (other): Severe depression/anxiety; increase in memory problems (05/2019 hemorrhagic stroke)
Release 9 — day 7, dose 2
Systemic reaction (other): Increase in depression/anxiety
Release 9 — day 35, dose 2
Symptoms: Severe depression and anxiety.
Release 9 — day 42, dose 2
Symptoms: Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | · | ✓ |
| SD | Depression | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Memory impairment | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release